307 related articles for article (PubMed ID: 22606042)
1. Phage displayed peptides/antibodies recognizing growth factors and their tyrosine kinase receptors as tools for anti-cancer therapeutics.
Ronca R; Benzoni P; De Luca A; Crescini E; Dell'Era P
Int J Mol Sci; 2012; 13(4):5254-5277. PubMed ID: 22606042
[TBL] [Abstract][Full Text] [Related]
2. A Novel Artificially Humanized Anti-Cripto-1 Antibody Suppressing Cancer Cell Growth.
Ishii H; Zahra MH; Takayanagi A; Seno M
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567764
[TBL] [Abstract][Full Text] [Related]
3. Generation of Recombinant Antibodies Against Toxins and Viruses by Phage Display for Diagnostics and Therapy.
Unkauf T; Miethe S; Fühner V; Schirrmann T; Frenzel A; Hust M
Adv Exp Med Biol; 2016; 917():55-76. PubMed ID: 27236552
[TBL] [Abstract][Full Text] [Related]
4. Phage Display Technology as a Powerful Platform for Antibody Drug Discovery.
Nagano K; Tsutsumi Y
Viruses; 2021 Jan; 13(2):. PubMed ID: 33504115
[TBL] [Abstract][Full Text] [Related]
5. The selection performance of an antibody library displayed on filamentous phage coat proteins p9, p3 and truncated p3.
Huovinen T; Syrjänpää M; Sanmark H; Seppä T; Akter S; Khan LM; Lamminmäki U
BMC Res Notes; 2014 Sep; 7():661. PubMed ID: 25238965
[TBL] [Abstract][Full Text] [Related]
6. Harnessing Phage Display for the Discovery of Peptide-Based Drugs and Monoclonal Antibodies.
Li Y; Liu M; Xie S
Curr Med Chem; 2021; 28(40):8267-8274. PubMed ID: 33176631
[TBL] [Abstract][Full Text] [Related]
7. Phage-Displayed Peptides for Targeting Tyrosine Kinase Membrane Receptors in Cancer Therapy.
Aloisio A; Nisticò N; Mimmi S; Maisano D; Vecchio E; Fiume G; Iaccino E; Quinto I
Viruses; 2021 Apr; 13(4):. PubMed ID: 33918836
[TBL] [Abstract][Full Text] [Related]
8. Phage Display Technology for Human Monoclonal Antibodies.
Dal Ferro M; Rizzo S; Rizzo E; Marano F; Luisi I; Tarasiuk O; Sblattero D
Methods Mol Biol; 2019; 1904():319-338. PubMed ID: 30539478
[TBL] [Abstract][Full Text] [Related]
9. The role of phage display in therapeutic antibody discovery.
Chan CE; Lim AP; MacAry PA; Hanson BJ
Int Immunol; 2014 Dec; 26(12):649-57. PubMed ID: 25135889
[TBL] [Abstract][Full Text] [Related]
10. Construction of human antibody gene libraries and selection of antibodies by phage display.
Frenzel A; Kügler J; Wilke S; Schirrmann T; Hust M
Methods Mol Biol; 2014; 1060():215-43. PubMed ID: 24037844
[TBL] [Abstract][Full Text] [Related]
11. Generation of Potent Anti-Vascular Endothelial Growth Factor Neutralizing Antibodies from Mouse Phage Display Library for Cancer Therapy.
Lai YD; Wu YY; Tsai YJ; Tsai YS; Lin YY; Lai SL; Huang CY; Lok YY; Hu CY; Lai JS
Int J Mol Sci; 2016 Feb; 17(2):214. PubMed ID: 26861297
[TBL] [Abstract][Full Text] [Related]
12. Dual display: phage selection driven by co-engagement of two targets by two different antibody fragments.
Fagète S; Botas-Perez L; Rossito-Borlat I; Adea K; Gueneau F; Ravn U; Rousseau F; Kosco-Vilbois M; Fischer N; Hartley O
Protein Eng Des Sel; 2017 Sep; 30(9):575-582. PubMed ID: 28444391
[TBL] [Abstract][Full Text] [Related]
13. Phage display technology for human monoclonal antibodies.
Deantonio C; Cotella D; Macor P; Santoro C; Sblattero D
Methods Mol Biol; 2014; 1060():277-95. PubMed ID: 24037846
[TBL] [Abstract][Full Text] [Related]
14. A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2).
Boshuizen RS; Marsden C; Turkstra J; Rossant CJ; Slootstra J; Copley C; Schwamborn K
MAbs; 2014; 6(6):1415-24. PubMed ID: 25484047
[TBL] [Abstract][Full Text] [Related]
15. Selection of high affinity human neutralizing antibodies to VEGFR2 from a large antibody phage display library for antiangiogenesis therapy.
Lu D; Jimenez X; Zhang H; Bohlen P; Witte L; Zhu Z
Int J Cancer; 2002 Jan; 97(3):393-9. PubMed ID: 11774295
[TBL] [Abstract][Full Text] [Related]
16. Identification of a RON tyrosine kinase receptor binding peptide using phage display technique and computational modeling of its binding mode.
Zarei O; Benvenuti S; Ustun-Alkan F; Hamzeh-Mivehroud M; Dastmalchi S
J Mol Model; 2017 Aug; 23(9):267. PubMed ID: 28823053
[TBL] [Abstract][Full Text] [Related]
17. Review of phage display: A jack-of-all-trades and master of most biomolecule display.
Song BPC; Ch'ng ACW; Lim TS
Int J Biol Macromol; 2024 Jan; 256(Pt 2):128455. PubMed ID: 38013083
[TBL] [Abstract][Full Text] [Related]
18. Isolation of monoclonal antibody fragments from phage display libraries.
Arbabi-Ghahroudi M; Tanha J; MacKenzie R
Methods Mol Biol; 2009; 502():341-64. PubMed ID: 19082566
[TBL] [Abstract][Full Text] [Related]
19. High-content analysis of antibody phage-display library selection outputs identifies tumor selective macropinocytosis-dependent rapidly internalizing antibodies.
Ha KD; Bidlingmaier SM; Zhang Y; Su Y; Liu B
Mol Cell Proteomics; 2014 Dec; 13(12):3320-31. PubMed ID: 25149096
[TBL] [Abstract][Full Text] [Related]
20. Phage display and hybridoma generation of antibodies to human CXCR2 yields antibodies with distinct mechanisms and epitopes.
Rossant CJ; Carroll D; Huang L; Elvin J; Neal F; Walker E; Benschop JJ; Kim EE; Barry ST; Vaughan TJ
MAbs; 2014; 6(6):1425-38. PubMed ID: 25484064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
